Imperial College London

DrAmeliaShoemark

Faculty of MedicineNational Heart & Lung Institute

Honorary Research Associate
 
 
 
//

Contact

 

+44 (0)20 7351 8428a.shoemark02

 
 
//

Location

 

Electron microscopy unitSydney StreetRoyal Brompton Campus

//

Summary

 

Summary

Amelia is a registered clinical scientist working at the Royal Brompton Hospital, London, where she leads the scientific service for the diagnosis of Primary Ciliary Dyskinesia (PCD).

PCD is an inherited condition affecting 1 in 20,000 people in the UK (www.pcdsupport.org.uk). Cilia are small organelles which line the surface of the nose and lungs. Their job is to clear mucus and protect the airways from infection. Amelia’s research interests concern the improvement of diagnosis and management for patients with ciliary dysfunction. Her research is funded by a NIHR fellowship.

Amelia lectures at Imperial College and supervises MSc and BSc students.

 

.

Publications

Journals

Shoemark A, Moya E, Hirst RA, et al., 2018, High prevalence of CCDC103 p.His154Pro mutation causing primary ciliary dyskinesia disrupts protein oligomerisation and is associated with normal diagnostic investigations., Thorax, Vol:73, Pages:157-166

Shoemark A, 2017, Haemophilus influenzae biofilms in primary ciliary dyskinesia: a moving story, European Respiratory Journal, Vol:50, ISSN:0903-1936

Irving S, Carr S, Hogg C, et al., 2017, Lung Clearance Index (LCI) is Stable in Most Primary Ciliary Dyskinesia (PCD) Patients Managed in a Specialist Centre: a Pilot Study, Lung, Vol:195, ISSN:0341-2040, Pages:441-443

Shoemark A, Frost E, Dixon M, et al., 2017, Accuracy of Immunofluorescence in the Diagnosis of Primary Ciliary Dyskinesia, American Journal of Respiratory and Critical Care Medicine, Vol:196, ISSN:1073-449X, Pages:94-101

Olcese C, Patel MP, Shoemark A, et al., 2017, X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3, Nature Communications, Vol:8, ISSN:2041-1723

More Publications